AlphaCentric Advisors LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
AlphaCentric Advisors LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2022$211,500
-78.5%
50,000
-88.0%
0.21%
-79.3%
Q3 2022$984,000
-19.1%
415,000
+3.8%
1.01%
+185.3%
Q4 2021$1,216,000
+16.8%
400,000
+169.4%
0.35%
+33.6%
Q3 2021$1,041,000
+183.7%
148,500
+271.2%
0.26%
+165.0%
Q2 2021$367,000
+89.2%
40,000
+100.0%
0.10%
+53.8%
Q1 2021$194,000
+100.0%
20,000
+110.5%
0.06%
+62.5%
Q4 2020$97,0009,5000.04%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders